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Surface plasma treatment techniques for modification of biomedical polymeric materials are presented. The emphasis is on the
use of non-equilibrium radiofrequency (RF) oxygen and nitrogen plasma. By variation of discharge parameters (power,
discharge frequency, type of gas) and plasma parameters (density of neutrals and ions, kinetic energy of electrons, gas
temperature) it is possible to produce polymer surfaces with different surface properties. Already after short plasma treatment
time the surface of polymeric material becomes hydrophilic. Formation of nitrogen and oxygen functional groups is observed
immediately after plasma treatment. By optimisation of plasma treatment time the number of newly formed functional groups
can be increased. Plasma treatment also produces morphological changes of the surface; nanohills of different shapes and height
can be formed on PET surface depending on the treatment time and type of gas. Evidently the change in surface morphology
affects the change in surface roughness, which increases with longer plasma treatment time. Plasma treatment influences also on
the biological response, as all plasma treated surfaces exhibit improved proliferation of fibroblast and endothelia cells. The
number of adherent platelets practically does not change after nitrogen plasma treatment, however much lower number of
adherent platelets is observed on oxygen plasma treated surfaces.
Key words: plasma treatment, biocompatibility, polymer, vascular grafts, endothelia cells, platelets
Predstavljene so tehnike plazemske obdelave povr{in, s katerimi lahko modificiramo povr{ine biomedicinskih polimernih
materialov. Poudarek je na uporabi neravnovesne radiofrekven~ne (RF) plazme du{ika in kisika. S spreminjanjem
razelektritvenih (mo~, razelektritvena frekvenca, vrsta plina) in plazemskih parametrov (gostota nevtralnih delcev, ionov,
kineti~ne energije elektronov, temperature plina) je mogo~e pripraviti povr{ine polimerov z razli~nimi lastnostmi. @e po kratkih
~asih izpostavitve polimernih povr{in du{ikovi ali kisikov plazmi le-ta postane hidrofilna. Takoj po obdelavi je na povr{ini
mogo~e opaziti novonastale du{ikove oziroma kisikove funkcionalne skupine. Z optimizacijo ~asa izpostavitve plazmi je
mogo~e koncentracijo le-teh {e nekoliko pove~ati. Plazemska obdelava vpliva tudi na spremembe v morfolo{kih lastnostih
povr{ine, tako je mogo~e na plazemsko obdelanih povr{inah opaziti nanostrukture, katerih oblika in velikost je odvisna od ~asa
izpostavitve plazmi, kot tudi od vrste plina uporabljenega za plazmo. Morfolo{ke spremembe vplivajo tudi na spremembe v
hrapavosti povr{ine, ki se pove~a s ~asom plazemske obdelave. Modifikacija povr{ine vpliva na biolo{ki odziv, saj se po
plazemski obdelavi proliferacija endotelijskih in fibroblastnih celic na povr{ini pove~a. [tevilo adheriranih trombocitov na
povr{inah, obdelanih z du{ikovo plazmo, se bistveno ne spremeni, medtem ko se njihovo {tevilo bistveno zmanj{a na povr{inah,
obdelanih s kisikovo plazmo.
Klju~ne besede: plazemska obdelava, biokompatibilnost, polimer, umetne `ile, endotelijske celice, trombociti
1 INTRODUCTION
Surface properties of biomaterials play a major role
in determining biocompatibility; they have a significant
influence on biological response and also determine the
long term performance in vivo. The main goal in
designing biomaterials is therefore to ensure that they
exhibit appropriate surface properties as well as desired
physical and mechanical characteristics, which would
enable them to function properly in the biological envi-
ronment. It is hard to satisfy all of these characteristics;
this is why surface treatment techniques are commonly
employed in order to improve surface properties. It is
still a highly challenging task to modify surface
properties in order to produce hemocompatible surfaces,
and many controversial results are reported in the
literature.
Biological response to biomaterials is very complex
and still not fully understood. As the surface of the
biomaterial is responsible for initiating the primary
interaction with body fluids it is of vital importance to
ensure that the surface is suitably conditioned to ensure
an appropriate biological response (biocompatibility). It
was thought for many years that the surface of the
biomaterial should be inert. However, nowadays it has
been found that the contact of biomaterials with blood
enables integration with the body, prevents infections,
inflammatory reactions, blood coagulation and other
correlated reactions. It is of primary importance that the
surfaces of hemocompatible materials exhibit anti-
thrombogenic properties, as this prevents thrombosis.
Thrombosis is initiated with the adsorption of blood
plasma proteins on the surface of the biomaterial and is
strongly influenced by its physical and chemical
properties.
Surface properties of implants are usually described
with wettability, chemistry, surface charge and texture
(roughness). These factors all influence the sequence of
protein adsorption and subsequent platelet adhesion/
thrombus formation. Although the mechanism of
occlusion and dysfunction of artificial prostheses is
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multifactorial, all the studies performed suggest that
fibrinogen and platelet deposition play a predominant
role.1,2 It also seems that the outermost atomic layer of
the surface of an alloplastic implant is a decisive factor
for determining biocompatibility.3 One possible method
to alter surface characteristics, such as wettability, che-
mistry, charge and morphology to improve biocompa-
tibility of implant devices4 is by treatment of the surface
with different gaseous plasma, like glow discharge
created in different gases and by variation of discharge
parameters (discharge power, pressure, etc.),5 which in
turn influence plasma parameters (density of atoms,
energy of plasma particles, etc.). Plasma modification
has been used recently to enhance biocompatibility of
implant devices made from stainless steel, titanium and
various polymers.6–14 The unique advantage of plasma
modification of implant devices is that the surface can be
modified without altering the bulk properties of the
material.15 It is thus possible to obtain desired mecha-
nical and physical properties of implant material and at
the same time also improve its surface properties to
accomplish biocompatibility.
2 SURFACE MODIFICATION BY PLASMA
TREATMENT
Combined surface treatments incorporating photons,
ions and electrons and some other excited particles, are
found in gas-electric discharges, often denominated
plasmas. Ionised gas is usually called plasma when it is
electrically neutral (i.e., electron density is balanced by
that of positive ions) and contains a significant number
of electrically charged particles, which is sufficient to
affect its electrical properties and behaviour.16 Therefore
plasma is composed of highly excited atomic, molecular,
ionic, and other native radical species. It is typically
obtained when gases are excited into energetic states by
radio-frequency (RF), microwave, or electrons from a
hot filament discharge. To produce plasma, electron
separation from atoms or molecules in gas state, or
ionization is required. When an atom or a molecule gains
enough energy from an outside excitation source or via
interaction (collisions) with one another, ionization
occurs.17
Plasmas are divided into thermodynamically balanced
and unbalanced. Plasma characteristics are dependent
upon the electrical discharge type, the type of gas or
gaseous mixture, and the pressure. Thermodynamically
balanced plasmas are characterized by very high
temperatures of heavy particles (often about 10 000 K).
These types of plasmas are not suitable for the treatment
of polymeric materials, as the gas temperature is so high
as to cause their thermal degradation. While in thermo-
dynamically unbalanced plasma the gas temperature is
significantly lower, as they are composed of low tempe-
rature heavy particles (charged and neutral molecular
and atomic species) and very high temperature electrons
(often about 50 000K). This type of plasmas are are
suited for the treatment of delicate polymeric pro-
ducts18–32 such as PET, PDMS or PTFE, which are used
for biomedical applications.
Clark and Hutton33 showed that with hydrogen
plasma they can rapidly defluorinate fluoropolymers to a
depth of 2 nm. On the other hand it was reported that
plasma treatment with oxygen increased endothelia cell
attachment on vascular grafts made of PTFE.34 Compa-
rison of plasma treatment with oxygen, nitrogen and gas
mixture of nitrogen and oxygen, where conducted by M.
Chen et al., where it has been shown that the mixture of
gases uniquely modifies PTFE surfaces and reduces
levels of inflammatory cells.5 Surfaces having incor-
porated nitrogen were more effective than those of
oxygen containing functional groups in promoting cell
adhesion.35 Though, appropriate surface modification is
not only a function of working gas, but also of other
discharge parameters, such as pressure, type of gas,
power etc. Chevallier et. al. showed that nitrogen plasma
treatment of PTFE at low-power (10 W) experimental
conditions exhibits more alkene and less amino groups
formed on the surface than a higher-power plasma
treatment (20 W). Consequently, surface chemistry could
be modulated through appropriate selection of discharge
parameters.36
In our investigation surface properties of polymeric
biomedical implants have been tailored by RF oxygen
and nitrogen plasma treatment. The PET polymeric
implants were treated in the experimental system shown
in Figure 1. The plasma was created with an inductively
coupled RF generator, operating at a frequency of 27.12
MHz and an output power of about 200 W. The plasma
parameters were measured with a double Langmuir
probe and a catalytic probe36–44. In our experiments, the
pressure was fixed at 75 Pa, as at this pressure the
highest degree of dissociation of molecules, as measured
by the catalytic probes, was obtained. At these discharge
parameters, plasma with an ion density of about 2 · 1015
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Figure 1: The RF plasma reactor chamber with the sample in position
Slika 1: Cev RF plazemskega reaktorja z vzorcem
m–3, an electron temperature of 4 eV, and neutral atoms
density of about 4 · 1021 m–3 for oxygen plasma and
about 1 · 1021 m–3 for nitrogen plasma was obtained.
After plasma treatment surface chemistry, wettability and
topography was altered.
Change in chemical composition was determined
from (x-ray photolelectron spectroscopy) XPS. It has
been shown that newly formed oxygen, or nitrogen
functional groups are formed on the surface, depending
on the type of gas used for modification. Already after
short exposure to oxygen plasma the increase in oxygen
concentration from initial mole fraction 21 % to 39 %
was observed. With prolonged exposure to oxygen
plasma the concentration slowly increased, and at 90 s it
reached 44 %. On nitrogen plasma treated samples
nitrogen concentration increased from 0 % to 12 % after
3 s of treatment time, and after 90 s of treatment it
reached about 14 %. During nitrogen plasma treatment a
small increase in oxygen concentration was also ob-
served.
Wettability was examined immediately after the
plasma treatment by measuring the water contact angle
with a demineralised water droplet of a volume of 3 μL.
The relative humidity (45 %) and temperature (25 °C)
were monitored continuously and were found not to vary
significantly during the contact angle measurements.
Contact angle measurements show a decrease in contact
angles after oxygen and nitrogen plasma treatment
Figure 2, corresponding to a higher hydrophilicity of the
polymer surface. During the water contact angle
measurements room temperature was 21 °C and The
oxygen plasma treated samples exhibit lower values of
contact angles, and thus demonstrating that this treat-
ment provides a higher hydrophilic character. Even after
short exposure times the surfaces show an increased
hydrophilicity, regardless of the type of gas used. The
treatment with nitrogen plasma, however, seems to be
less efficient in reaching high hydrophilicity. However
the high hydrophilycity of oxygen plasma treated sur-
faces could be attributed to degradation products, which
are formed on the surface after longer treatment times
and could cause a lower contact angle, due to surface
roughening.
The morphology of untreated and plasma treated
surfaces was analyzed by atomic force microscopy
(AFM) and scanning electron microscopy (SEM). In
both cases change in surface morphology was observed.
In Figure 3 phase AFM images are shown. In Figure 3 a
surface of untreated sample is shown, while in Figure 3
b and c change in surface morphology after treatment in
nitrogen and oxygen plasma can be observed, respec-
tively. Untreated sample has smooth surface, without any
particular features on the surface, while treated samples
exhibit small nanostructures on its surface. The diffe-
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Figure 3: Phase AFM images of PET polymer; a) untreated, b) treated
for 90 s in nitrogen plasma and c) treated for 90 s in oxygen plasma
Slika 3: Fazne AFM-slike PET polimera; a) neobdelanega, b) obde-
lanega 90 s v du{ikovi plazmi in c) obdelanega 90 s v kisikovi plazmi
Figure 2: Water contact angle measured on the PET polymer as a
function of treatment time and plasma gas, () oxygen plasma
treatment, () nitrogen plasma treatment
Slika 2: Kontaktni kot vodne kapljice, izmerjen na povr{ini PET
polimera, v odvisnosti od ~asa obdelave in vrste plina, () obdelava v
kisikovi plazmi, () obdelava v du{ikovi plazmi
rence between the samples treated with oxygen (Figure
3 a) and nitrogen (Figure 3 b) plasma is noticeable: the
samples treated by oxygen plasma have structures which
are higher and further apart, than those treated with
nitrogen plasma. This could be attributed to highly
oxidative nature of oxygen plasma. However the height
of these nanostructures is not only dependent on the type
of gas employed for treatment, but also on the treatment
time. By longer treatment time the height of these nano-
structures can be increased, especially for the case of
oxygen plasma treatment. Due to growth of nanostruc-
tures, surface roughness is increased on these surfaces as
well.
3 BIOLOGICAL RESPONSE
To achieve a desired biological response, the attach-
ment of cells to the surface of biomaterials is of primary
importance. When a biomaterial is exposed to a living
organism many extremely complex reactions may occur
at the cell-biomaterial surface. These reactions include
coagulation, healing, inflammation, mutagenicity, and
carcinogenity and play an important role in the
successful implementation of the implemented material
or device45-48. Surface parameters, such as surface
chemistry, wettability, surface topography and surface
roughness influence protein adsorption, and the adsorbed
protein layer further dictates subsequent cellular
reactions. Thus, by carefully tailoring surface properties
by plasma treatment one could engineer the surface for a
specific protein adsorption which would lead to a desired
cellular response.
Gas plasma treatment is one of the strategies for
enhancing surface properties by enriching the surface
with new functional groups known to enhance cell
proliferation – such as oxygen or nitrogen.49,50 One of the
strategies to improve biocompatibility/hemocompatibi-
lity of the surface is to introduce new functional groups,
such as hydroxyl (-OH), amine (-NHx), methyl (-CH3)
sulphate (-SO4) or carboxylic (-COOH).51–54 This is
either employed to tailor the biological response (im-
prove cell proliferation, reduce platelet adhesion etc.) or
to enable immobilisation of biomolecules (enzymes,
proteins etc.). The effects of functional groups on
hemocomaptibilility have been extensively studied, but
again results are not always consistent. The study by
Wilson et. al. has shown that treatment of polymer
(polyethyetherurethane- PEU) surface with RF ammonia
and nitrogen plasma (incorporation of nitrogen groups)
significantly reduces contact activation54. However, no
changes in thrombogenicity, as compared to the un-
treated surface, were observed after oxygen and argon
plasma (incorporation of oxygen groups). Similar results
were obtained for RF plasma treatment of polydimethyl-
siloxane (PDMS) by Williams.55
On the other hand surface wettability is also believed
to be one of the important parameters which affect
biological response to a biomaterial. It is established that
protein adsorption is the first event that takes place on
the surface of a biomaterial with biological fluids,52–54
and that the biological response is controlled by the
nature and confirmation of the proteins adsorbed to the
surface. Thus, wettability is believed to play an im-
portant role in the amount and conformational changes
of adsorbed proteins59 platelet adhesion/activation, blood
coagulation60 and adhesion of cells.61,62
Generally hydrophobic surfaces are considered to be
more protein-adsorbent than hydrophilic surfaces, due to
strong hydrophobic interactions occurring at these
surfaces.63–65
Nevertheless surface morphology should also be
taken in account when talking about biological response
to biomaterials. Surface morphology is important in
protein adsorption and subsequent cell response. Reidel
and colleagues showed that adsorption of albumin dra-
matically increased due to presence of nanoislands.66
While Vertegel et. al. showed that the adsorption of lyso-
zyme to silica nanoparticles decreased with decreasing
nanoparticle size67. Surface topography plays an import-
ant role in providing three-dimensionality of cells68. For
instance the topography of the collagen fibres, with
repeated 66 nm binding, has shown to affect cell shape.69
It has been shown that RF oxygen and nitrogen
plasma treatment improve proliferation of fibroblast as
well as endothelia cells. Figure 4 shows the measured
absorbance, which is directly proportional to viability of
endothelia cells, cultured on different samples. These
results show that proliferation of endothelia cells is
improved on all plasma treated surfaces, which is in
accordance with the results published in the literature.5, 70
Improved proliferation of cells can be attributed to newly
formed functional groups (oxygen and nitrogen) intro-
duced after short plasma treatment time (3 s), as well as
to higher hydrophilicity of the surface, surface morpho-
logy etc. It seems that longer treatment time (longer than
30 s) by oxygen plasma is more affective in promoting
endothelia cell attachment than nitrogen plasma.
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Figure 4: Viability of endothelia cells (HUVEC) cultured on surfaces
treated by oxygen and nitrogen plasma for different treatment times
Slika 4: Viabilnost endotelijskih celic (HUVEC) na povr{inah, obde-
lanih s kisikovo in du{ikovo plazmo pri razli~nih ~asih obdelave
Endothelia cell seeding is a common approach to
improving hemocompatibility of vascular grafts, as
endothelia cells are thought to be an ideal hemocompa-
tible surface. However adhesion of platelets is not
desired for hemocompatible surfaces. Thus lower or
practically no adhesion of platelets would be desired.
Interestingly our study showed significant differences in
adhesion of platelets to oxygen and nitrogen plasma
treated surfaces. Observable differences in the number of
adherent platelets and their shape can be seen in Figure
5. The number of adherent platelets decreased dramati-
cally on oxygen plasma treated surfaces; as can be seen
from Figure 5 c after only 3 s of oxygen plasma treat-
ment, a lower number of platelets was observed. Those
that did adhere seemed to be in a more round form,
which is thought to be attributed to low platelet activity.
On the contrary there were many aggregated platelets on
untreated (Figure 5 a) and nitrogen plasma treated sur-
faces (Figure 5 b). Fibrin formation was also observed
on these surfaces, especially on the untreated surface.
The platelets on the untreated polymer surface are
mostly in well spread form and start to aggregate.
4 CONCLUSIONS
It has been shown that plasma treatment techniques
enable surface modification of biomedical materials and
thus enable desired biological response of the surface.
Therefore many biomedical materials have been treated
by plasma in order to improve their surface properties to
accomplish biocompatibility. By fine tuning the dis-
charge and plasma parameters the surface can be appro-
priately modified.
Our study showed that by oxygen and nitrogen
plasma treatment surface chemistry, wettability and
morphology can be altered. Furthermore plasma
treatment enables improved proliferation of fibroblast
and endothelia cells and influences on adhesion pro-
perties of platelets. Interestingly adhesion of platelets
was noticeably reduced on oxygen plasma treated surfa-
ces, while adhesion on nitrogen plasma treated surfaces
was similar to the untreated ones. It has been shown that
oxygen plasma treatment is a promising way to improve
hemocompatible properties of PET surface, as surfaces
modified in this manner exhibit improved proliferation
of endothelia cells and reduced platelet adhesion.
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